Overview

Management

Advisors

Funding

Contact

Overview

Circulomics is a Maryland biotechnology company located within Johns Hopkins' FastForward Business Accelerator that spun out of the $14M Center of Cancer Nanotechnology Excellence. Our vision is to commercialize a large portfolio of micro-, nano-, and single molecule technologies that will streamline every step in the molecular analysis workflow from front-end sample preparation to assays and detection instruments. These technologies include our Nanobind DNA/RNA extraction technology, Ligo-miR microRNA assay technology, and PicoSep single molecule analysis system.

Circulomics has received $4.3M in grant funding to develop innovative platforms for microRNA profiling, single molecule analysis, and nucleic acid sample preparation that will drive the research and clinical translation of genomics technologies from sequencing to expression profiling and biomarker analysis.

Stieff